NEW YORK, July 22, 2003 (PRIMEZONE) -- Amid the FDA's new initiative to more aggressively protect American consumers from counterfeit and adulterated drugs, leading Bio/Pharmaceutical companies, Homeland Security, FDA Product Surety Working Group, WHO, CDC, US Customs, USP, healthcare distributors, security professionals, and legal experts address the Security and Competency of the Drug Supply Chain at The Institute for International Research's September Pharmaceutical Supply Chain Integrity Conference. This event is being held September 24-26 at The Fairmont Hotel in Washington, DC. To view the complete agenda, visit: http://www.iirusa.com/trax/Index.cfm/Link=1/newsection=yes/prioritycode=P0922XPZM
Elizabeth Durant, Executive Director, Trade Compliance and Facilitation, Homeland Security, Bureau Of US Customs And Border Protection, will discuss counterfeit drugs distributed over the Internet as well as other Homeland Security concerns.
According to John Dempsey, Executive Director, Trade Relations & Brand Security for Ortho Biotech Products, LP "Counterfeit drugs continues to be an issue of great importance to all manufacturers as it relates to the safety of the customers they serve. It is critical that we pool our resources and knowledge and work together in eradicating counterfeit drugs from the marketplace."
Mr. Dempsey joins featured presenters at the September conference including: Elizabeth Durant, Executive Director, Trade Compliance and Facilitation, Homeland Security, Bureau of US Customs and Border Protection, Eshetu Wondemagegnehu , World Health Organization, Neil C. Livingstone, GlobalOptions, Benjamin England, former regulatory counsel to the FDA now with Hogan and Hartson, and Geoff Power, Director of Packaging Security, GlaxoSmithKline.
This industry-centric conference will address recently evoked concerns about the security and competency of the US drug supply chain for a number of critical reasons including: increased regulatory focus on supply chain issues including the recent FDA barcode proposal and the FDA Initiative to combat counterfeit drugs; the exponential growth of illegal on-line pharmacies; the heightened sensitivity to terrorist activity; and recent legislation on reimportation. The rise in the production of environmentally sensitive biologics are also addressed in this conference.
To download the brochure PDF, please visit:
http://www.iirusa.com/trax/index.cfm/Action=PDF/t=m/prioritycode=P0922XPZM
REGISTRATION (early registration recommended):This event is open for registration. Register today at:
http://www.iirusa.com/trax/index.cfm/Link=8/newsection=yes/prioritycode=P0922XPZM
Or, call (888) 670-8200. Please reference priority code P0922XMNPR when registering or inquiring about this event.
About the Institute for International Research
The Institute for International Research (IIR) is the world's largest conference company and has been the leader in the provision of business information for over 20 years. IIR produces over 5,000 events annually through our network of offices in over 35 countries. For further details please visit us online at www.iirusa.com